Thursday, March 29, 2007

Journalists and scientists to talk about communication as a critical element of science

Biotech News

Journalists and scientists to talk about communication as a critical element of science

TEMPE, Ariz. — Some of the nation’s leading scientists and science journalists will present their perspectives on the roles of scientists and engineers in popular communication during a symposium April 2 at Arizona State University titled “Essential Dialogues: Why Scientists and Engineers Must Not Speak in Tongues.”

The symposium, sponsored by the Hendricks Family Foundation, is one of several activities planned this spring to mark the official launch of ASU’s School of Earth and Space Exploration, a groundbreaking endeavor in higher education that fuses Earth and space sciences with engineering.

“In today’s world, there can be no true ‘literacy’ without scientific literacy,” says Kip Hodges, professor and founding director of the school. “People need a basic understanding of how the universe works and how scientific principles inform the development of new technologies. And there can be no better ambassador for science and technology than a scientist or an engineer who can explain the importance of their work to non-specialists.”

The School of Earth and Space Exploration will make popular science and engineering communication an essential part of both the graduate and undergraduate curricula, according to Hodges. “In order to underscore this mission, we’ve gathered some of the nation’s top science writers and scientists to talk about how scientists and engineers can be most effective in how they communicate,” he says.

Among the speakers is Robert Irion, director of the science communication program at the University of California-Santa Cruz, who will address the theme of the symposium head on with his talk “Scientists as Journalists: Training the Next Generation.” Irion, who has an undergraduate degree in Earth and planetary sciences from the Massachusetts Institute of Technology and a graduate certificate from the UC-Santa Cruz program, is co-author of the award-winning book One Universe: At Home in the Cosmos. He also received the 2003 David Schramm Award in Science Journalism from the American Astronomical Society for a story in Science magazine about neutron stars.

Natalie Angier, a Pulitzer-Prize winning New York Times science journalist and non-fiction author, will talk about “Scientists and Journalists: Can’t We All Just Get Along?” The Barnard College graduate studied English, physics and astronomy while in college and dreamed of starting a popular magazine about science for intelligent lay readers. Instead, at the age of 22, she was hired as a founding staff reporter and writer for Discover, the science magazine that Time Inc. launched in 1980. Angier is the author of four books; her newest due out this spring is The Canon: A Whirligig Tour of the Beautiful Basics of Science, which she will talk about at a reception from noon to 1 p.m. April 3 in the Virginia G. Piper Writers House at ASU.

Charles Petit, who has covered science for more than 35 years as a newspaper, news magazine and freelance writer, will present his perspective in a talk titled “The Science Beat: News that Really is New.” Petit’s career includes 26 years at the San Francisco Chronicle and several years on staff at U.S. News & World Report. His recent work has appeared in National Geographic, Smithsonian Magazine and The New York Times. While he was at U.S. News, the American Association for the Advancement of Science awarded him its magazine science writing award for a set of articles on fusion research, on the first peopling of the Americas and on the computer adaptation of evolution as an engineering tool. Petit has a degree in astronomy from the University of California-Berkeley.

Seth Shostak, the senior astronomer at the SETI Institute, has written several hundred popular magazine and Web articles on various topics in astronomy, technology, film and television. He has an undergraduate degree in physics from Princeton University and a doctorate in astronomy from the California Institute of Technology. For much of his career, Shostak conducted radio astronomy research on galaxies, and has published nearly 60 papers in professional journals. Each week he hosts the SETI Institute’s science radio show “Are We Alone?” broadcast on Discovery Channel Radio. His talk at the symposium is titled “Science Searches for Extraterrestrials.”

Tom Levenson, an award winning writer-producer, is an associate professor of science writing at the Massachusetts Institute of Technology. Author of several books, including the acclaimed biography Einstein in Berlin, Levenson also is a Peabody and Emmy award-winning documentary filmmaker who has produced a number of prime-time science documentaries. He has had several articles and reviews published in The Atlantic Monthly, The Boston Globe, Discover and The Sciences. Levenson, who has an undergraduate degree from Harvard University, will present the talk “Against ‘Science Literacy.’”

The symposium will be held from 8 to 11:30 a.m. in the Biodesign Institute Auditorium, B Building, on ASU’s Tempe campus.

Also planned as part of the official launch activities is a second symposium titled “Emerging Vistas: The New Golden Age of Exploration.” Scheduled from 8 a.m. to 3:30 p.m. April 10, this symposium includes international leaders in field-based scientific research as well as space and undersea exploration. The symposium will be held in the Biodesign Institute Auditorium, B Building, on ASU’s Tempe campus. It will be followed by a reception and official launch ceremony with ASU President Michael M. Crow at 4:30 p.m. in the Administration Building A Courtyard.

An evening lecture – “Lunar Field Exploration: the Post-Shoemaker Era” – will be presented at 7:30 April 10 in Armstrong Hall by Harrison H. Schmitt, an Apollo astronaut and former U.S. senator. Schmitt will receive the Shoemaker Memorial Award, presented by BEYOND, ASU’s Center for Fundamental Concepts in Science.

All events are free and open to the public. Seating is limited and reservations are recommended. Registration and additional information are available at or (480) 965-5081.

AZhttp, Inc.

Friday, March 23, 2007

Biotech News

Biotech News

Biotech to See 10.1% Sales CAGR Between 2005 and 2011 According to ...
Genetic Engineering News (press release) - New Rochelle,NY,USA Biotech will be the fastest growing peer set with a 10.1% sales CAGR 2005-11. Biotech is almost totally insulated from generic threat because
(1) biotech ...

Study says state biotech shouldn't follow Ireland model - Charlotte,NC,USA ... government spending and regulation were responsible for Ireland's recent economic growth rather than public subsidies and tax breaks aimed at biotech. ...

MICKEL CONGRATULATES BIOTECH CEOS FOR BOOM IN INDUSTRY Media Newswire (press release) - New York,NY,USA “This growth is mainly due to increases in the size of existing biotech companies and reflects the maturing of the sector and companies moving down the ...

Biotech Day in Review: Eisai Buys Morphotek for $325 Million Seeking Alpha - New York,NY,USA Centient Biotech Investor submits: Eisai, the large Japanese Pharma, will acquire privately held Morphotek of Philadelphia for $325 million over its net ...

Private Equity and Biotech: Yet Another Data Point for Convergence By Roger Ehrenberg So I write about KKR booking less risk, and now I read about private equity going high-risk by wading into the quagmire of biotech? I have written extensively about convergence in the past, but what gives? ...

Friday's Top Biotech & Medical Stocks
by HS Ayoub BioHealth Biotechnology PIPEX PHARMACEUTICAL [PPXP.OB] +23.08% NEUROCRINE BIOSCI [NBIX] +13.72% IMCLONE SYSTEMS [IMCL] +13.64% DENDREON CORP [DNDN] +13.16% TITAN PHARMA INC [TTP] +7.73% Diagnostic. ...

Stem Cells are Where Biotech Was 30 Years ago - An Interview with ...
By pharmamanufacturing
“Biotech needs stem cell research,” he says, and the first stem cell-based treatments for auto-immune diseases, may be coming through the FDA cycle in about two years, he says. Play Video Stem Cell Industry Where Biotech was 30 years ...

Biotechnology: Biofuels spark biotech rally SAN FRANCISCO - Biotechnology was first applied in medicine, then farming. Today, dozens of lifesaving drugs are on the market, while many crops are genetically engineered to withstand weed killers.

Biotech babies
On Wired today, Steven Edwards broadens the discussion of genetically altering preborn gays, if that theory holds true, to genetically altering anyone for any reason. He linked an article describing a March 20 meeting at Harvard of some ...

AZhttp, Inc.

SofTECH Expert Panel Discussion on Biotech

Biotech News

SofTECH Expert Panel Discussion on Biotech in the North Bay - the

San Francisco,CA,USA There is growing Biotech industry in the North Bay. Being located away from the major biotech hubs presents special challenges and opportunities.

SofTECH Expert Panel Discussion on Biotech in the North Bay - the Challenges and Opportunities Faced by Biotech Firms in Marin and Sonoma Counties, on March 28

SofTECH will feature an expert panel to discuss Biotech in the North Bay.

There is growing Biotech industry in the North Bay. Being located away from the major biotech hubs presents special challenges and opportunities.

Our panel represents some of the largest and most exciting biotech firms in the North Bay. They will provide us with background information about their companies, and their unique viewpoints on doing business away from the large biotech centers.

Our audience will have the opportunity to pose questions to the panel.


Lee Jensen, Ph.D.
Chief Executive Officer
Bio Online


Barbara McShane
Director of Information Technology

Allan Lees
Chief Information Officer
Buck Institute for Age Research


Mark Ginnebaugh
Program Director
About SofTECH

SofTECH is a non-profit trade organization committed to fostering communication and cooperation for business and technology professionals in Northern California's Marin and Sonoma counties. Its goal is to identify and showcase technology leaders and support the technology user community. SofTECH develops programs and provides meaningful networking opportunities for its members. Please visit our Web site at:

Date: Wednesday, March 28, 2007


Autodesk, Inc.
111 McInnis Parkway
San Rafael, CA 94903


6:30 PM-7:15 PM Registration/Networking
7:15 PM-8:30 PM Panel Discussion and Questions

Registration Cost

Free to SofTECH members
$15 Non-members (Acteva Prepay)
$20 Non-members (if you pay at the door);
$10 Institutional/Student
Sign up for a Trial or Full Membership to SofTECH at:

AZhttp, Inc.

Biotech News

Biotech News
AZhttp, Inc.

M’rashtra signs MoUs with banks for biotech projects Financial Express - Bombay,India In line with the Maharashtra Biotechnology Policy, the Maharashtra Industrial Development Corporation (MIDC) has developed biotech research centres at Jalna ...

Anadys Pharmaceuticals to Present at BioCentury's Future Leaders ... (press release) - Newtown,PA,USA ... today that it will present at the BioCentury Future Leaders in the Biotech Industry Conference, Thursday, March 29, 2007 at 11:00 am ET (8:00 am PT). ...

President of Group That Promotes Md. Biotech Resigns Washington Post - Washington,DC,USA The president of MdBio, the principal organization that promotes and represents Maryland's biotech community, has resigned. ...

Tuesday, March 20, 2007

Biotech News

Biotech News AZhttp, Inc.

EDC To Get Briefing On Biotech Facility
Leesburg Today - Leesburg,VA,USA
The biotech research facility was created as a partnership of Virginia Commonwealth University, Richmond and the state and has brought together 50 ...

NC A&T Spins Out First Biotech Venture - Raleigh,NC,USA
GREENSBORO, NC – Provagen, the first company to be spun off from biotech research at North Carolina Agricultural and Technical State University, ...

2006-2015 billed as ‘biotech decade of Asia’
ABS CBN News - Philippines
Thus projected Dr. Clive James, founder and president of the International Service for the Acquisition of Agri- Biotech Applications (ISAAA). ...

Sabah Backs Development Of Biotech Sector Bernama - Kuala Lumpur,Malaysia Therefore, he said, the Sabah government would continue to support the development of the biotech industry in Sabah. In this respect, he said, ...

Nature Biotech recommends OA data
By Peter Suber
Democratizing proteomics data, Nature Biotechnology, March 2007. An editorial. (Thanks to Francis Ouellette.) Excerpt:. Beginning this month, Nature Biotechnology is recommending that raw data from proteomics and molecular-interaction ...

Euro-Biotech Forum 2007
By Donald Zuhn
By Donald Zuhn --- Windhover Information Inc. will be holding the 14th Annual Euro-Biotech Forum 2007 on June 26-28 in Paris, France. According to Windhover Information, Euro-Biotech offers European and American companies an opportunity ...

Biotech Mosquitoes Fight Malaria
By (Ronald Bailey)
The idea behind the new research is that since the biotech mosquitoes cannot become infected they win the reproductive race over wild ones. This would mean that once released, the population of malaria resistant moquitoes would increase ...

Malaysia Pins Hopes on Herbal Viagra for Biotech Push Malaysia's answer to Viagra is a traditional herb the country has picked to spearhead its push into biotechnology, but now it faces the challenge of convincing the world the remedy is both potent and safe.

Guest Viewpoint: Opening doors to Texas’ Biotech Corridor By John Galveston County Daily News, March 20, 2007By Larry Rohde I am excited to announce one of the latest additions to the University of Houston-Clear Lake’s degree program roster - the master of science in biotechnology degree. ...

Something Smells at Bodisen Biotech

Biotech News
AZhttp, Inc.

Annual Report Delay Indicates That Something Smells at Bodisen Biotech Seeking Alpha - New York,NY,USA David Phillips (10Q Detective) submits: In January, China-based Bodisen Biotech Inc. (BBC), which produces fertilizers and pesticides, announced it expected ...

Bodisen Biotech: Amex De-Listing, Sketchy Executive Stock Ownership Seeking Alpha - New York,NY,USA Herb Greenberg (MarketWatch) submits: Not only did Bodisen Biotech (BBC) announce that it's being de-listed, but it disclosed its CEO doesn't really own the ...

Maryland biotech raises $5 million
TechJournal South - Research Triangle Park,NC,USA ROCKVILLE, MD - Rockville-based biotech firm, Neuralstem, has raised $5 million in private equity funding to a group of institutional investors.

BioTech Medics Meeting With French Government Agency Officials SYS-CON Media - Montvale,NJ,USA BioTech through its UK agent MCM has been negotiating with EU and Asian distributors resulting in indications of SHBAN wholesale purchase orders aggregating ...

Tuesday, March 06, 2007

Biotech News

Biotech Helicos Plans Charts IPO
By DealBook
Helicos BioSciences, a 71-person firm trying to develop a faster way to analyze genes, is planning to go public in a $100 million stock offering. The Cambridge, Mass.-based company is the latest entry in the race to build a faster and ...

Ganeden Biotech warning letter
The FDA warning letter sent to medical foods marketer Ganeden Biotech and.

The Significance of the WTO Biotech Ruling for LAC By Keith R When the World Trade Organization (WTO) dispute panel on biotech products involving Argentina, Canada, and the US vs. the European Union (EU) released its report at the end of September, I sat down to start this entry with an outline ...

Biotech Weekly Review: Rough Week, IPOs Bright Spot By HSA(HSA) by Richard Daverman, PhD Centient Biotech Investor What a difference a week can make. Without doubt, last week was devastating for biotech. The Centient Biotech 200™ fell 232 points to 3822, a loss of 5.7% over the five sessions. ...

BioHealth Investor

Las Vegas' Ongoing Campaign Targeting New Jersey Biotech and Life Science Businesses

Las Vegas' Ongoing Campaign Targeting New Jersey Biotech and Life Science Businesses Attracts Response From State Business Development Center

Nevada Development Authority Launches Next Phase of Campaign Targeting New Jersey Businesses

LAS VEGAS, March 05, 2007 The Nevada Development Authority (NDA) begins the third phase of their business recruitment campaign that initially launched last August. The main thrust of the New Jersey campaign is aimed at targeting biotech and life science companies to relocate to Las Vegas. The ongoing NDA campaign promoting Las Vegas' pro-business environment and high- tech infrastructure has generated strong business interest and a recent rebuttal from some of New Jersey's business development officials.

In early February, the New Jersey Small Business Development Center (NJSBDC) distributed postcards to hundreds of New Jersey politicians and business leaders to dissuade local businesses from relocating to Las Vegas. The front of the postcard depicted a circle-and-slash no-entry sign that crossed out the word "Nevada." The front of the postcard stated, "Stay in New Jersey. NJSBDC will help you grow." The back of the card read, "When other states come knocking on your door to relocate your business-tell them where to go. Don't gamble with the future of your business," and "Businesses MADE in New Jersey STAY in New Jersey."

"Since we started our New Jersey campaign we've had many inquiries from businesses wanting to know more about Las Vegas. It seems to be working more on a grassroots level than we had initially thought. Now we're getting a totally different response from the business development side, which is combating our efforts," said Somer Hollingsworth, president and CEO of NDA. "We've seen this type of response before from business development in California where we've campaigned in the past. I think business development people are very territorial and they get nervous when they know they can't compete with Las Vegas and its pro-business environment, no personal income tax and no state corporate taxes."

In October 2006, to further Las Vegas' marketing campaign in New Jersey, NDA sent specialized Las Vegas Relocation Kits to a large number of the state's biotech and life science companies. The relocation kits promoted the benefits of living and conducting business in Las Vegas. NDA's goal was educating company presidents and CEOs with information on Las Vegas and its high-tech infrastructure, medical research and technology facilities and local foreign trade zone.

"Despite the refuting message from New Jersey, NDA plans to persist with future campaigns," said Hollingsworth. "The objective is to let companies know that Las Vegas is one of the best places in the country to do business. Our goal is to continue recruiting the rich biotech and life sciences industries on the eastern seaboard."

The new phase of the campaign will take the same approach, promoting a long list of top reasons to relocate or expand to Las Vegas.

Reasons to relocate or expand from the eastern region of the U.S. to Las Vegas:

1. Business-friendly state and local government
2. No state corporate income tax
3. No personal income tax
4. Excellent state incentives
5. Educated, expanding and cost-effective workforce
6. Best economic growth in the United States
7. America's finest telecommunications and technology infrastructure
8. Harry Reid 115-acre Research Technology Building
9. UNLV Science, Engineering and Technology Building
10. UNLV Supercomputing facility
11. Nevada Cancer Institute
12. Lou Ruvo Brain Institute
13. The Nevada Neurosciences Institute
14. Very dependable, expanding energy base
15. McCarran International Airport - America's 5th largest
16. Foreign Trade Zone #89

The mission of Nevada Development Authority is to attract, retain and expand the business base to enhance the overall socioeconomic environment of Southern Nevada. Established in Las Vegas in 1956, the NDA is Southern Nevada's largest economic development agency and contributes to the area's prosperity by attracting new companies and assisting local companies in expansion projects. For more information, please call 888-4-NO-TAXES or visit

CONTACT: James Woodrow, or Micaela Whalen,, both of Preferred Public Relations,+1-702-254-5704, for Nevada Development Authority

Web site:

NC fund leads $1.7 million funding of Maryland biotech firm

NC fund leads $1.7 million funding of Maryland biotech firm TechJournal South - Research Triangle Park,NC,USA ROCKVILLE, MD—Amulet Pharmaceuticals, which is working on treatments for diabetic complications and heart disease medical devices, has closed a $1.7 million ...

Biotech conference coming to UNCC

Biotech conference coming to UNCC
Charlotte Observer - Charlotte,NC,USA
A tour of the biotech campus, which is going up in downtown Kannapolis, also is planned. The university sponsors are UNCC, UNC Greensboro, ...

Biotech Industry Leaders Convene for First Ever Biotechnology Conference Held in Italy

Biotech Industry Leaders Convene for First Ever Biotechnology Conference Held in Italy

More than 1100 biotechnology executives from around the world were treated to a positive outlook from industry leaders as the first annual BIO-Europe Spring conference opened today in Milan, Italy. BIO-Europe Spring is the first ever global biotechnology conference held in Italy.

Reflecting the biotech industry's positive trajectory worldwide, Italy showcased its growing muscle as an industry hub. Commenting on Italy's biotechnology development, Dr. Roberto Spingardi, head of inward investment for InvestInItaly, the nation's organization for promoting investment: "Promoting Italian life sciences has been one of InvestInItaly's key priorities since the biotech sector has become strategic on a global scale. Italy is showing increasing growth and potential. For example, we recently supported two successful agreements between Italian and US companies: Tristar-IOM (Istituto Oncologico dell Mediterraneo) and Immunicon-Molmed."

Dr. Spingardi's comments were roundly supported by new data unveiled today in a 2007 report on the Italian biotech industry. According to the report the industry is now comprised of 222 companies, with over 4 billion euros in revenue, 1.2 billion euros in R&D investment and more than 14,000 employees, of whom almost one third engaged in R&D and a pipeline of over 40 products in an advanced stage of development of which 9 are already in phase 3. The report was conducted by Blossom Associati on behalf of Assobiotec, the Italian Bioindustry Association.

Roberto Gradnik, President of Assobiotec, called the data "very exciting." In his words: "The Italian biotech train departed in 2000 and, with every year, gathers ever-greater speed. Our industry has overcome obstacles that might have appeared insurmountable and now stands on a par with that of leading European countries. It is being driven by a system comprising companies, science parks and researchers, all characterized by high doses of dynamism and innovation."

According to Carola Schropp, Managing Partner of EBD Group, "We at BIO-Europe Spring are pleased that we can play a part in supporting the Italian biotech industry by holding our meeting in Milan. It should be clear to all after this conference that Italy is emerging as a preferred location for biotech development."

About EBD Group

EBD Group is the leading partnering firm for the global biotechnology industry. Since 1993, firms in the life sciences have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships that drive their business.

EBD Group's conferences (run in collaboration with leading industry partners and international trade associations such as BIO and Eucomed) include BIO-Europe, the world's largest stand-alone life science partnering conference; BIO-Europe Spring; the investor conference, BioEquity Europe (co-organized with BioCentury Publications); and the convergent medical technology partnering conference, BioDevice Partnering. EBD's novel, web-based, partnering software system is also used at numerous third-party events around the world. Outside of the conference format, EBD Group's consultants can provide hands-on assistance for firms seeking to in- or out-license products and technologies.

Friday, March 02, 2007

Biotech Consortium Touts Device to Speed Diagnosis

Feb 27, 2007 - Biotech Consortium Touts Device to Speed Diagnosis ...
The Advanced Medical Countermeasures Consortium, a group of researchers, physicians and scientists from medical schools and laboratories, this week emphasized the need for new technologies to accelerate the detection and treatment of ...

Tradition developer hopes to build biotech complex With construction under way at the Torrey Pines Institute for Molecular Studies' 100000-square-foot campus here, the city's largest developer is now working to get a biotechnology complex four times that size built next door.

Biotech company begins hiring
Iowa City Press Citizen - Iowa City,IA,USA A new biotech company has begun the hiring process that will lead to 178 new jobs. The National Genecular Institute, an affiliate of Dermacia Inc., ...

Biotech Day in Review: Xoma Signs $230 Million Partnership with Takeda Seeking Alpha - New York,NY,USA Centient Biotech Investor submits: Xoma (XOMA) extended its November 2006 partnership with Takeda to include more therapeutic antibodies. ...

Biotech Dates to Remember - USA
Successful biotech investors keep a close eye on the calendar. Regulatory decisions and clinical trial results move this sector, so it's important to stay ...

Biotech News

Recent Call by President Bush for the Increased Production of ... (press release) - Pearland,TX,USA London, UK -- US President, George Bush, is looking to the biotechnology industry to increase the domestic production of biofuels and the knock-on effect ...

BIO Announces Speakers For 2007 World Congress On Industrial ...
Hydrocarbon Online (press release) - Horsham,PA,USA Washington, DC - The Biotechnology Industry Organization (BIO) recently announced the keynote speakers for the World Congress on Industrial Biotechnology ...

Rhode Island Biotechnology Company Receives $ 368K Federal Grant ... (press release) - Newtown,PA,USA PROVIDENCE, RI--(BUSINESS WIRE)--Feb 28, 2007 - EpiVax, Inc, a leader in genome-derived vaccines, announced today that it has received a grant to reengineer ...

Athersys Completes GMP Manufacturing of Multistem(R) for Clinical ...
in the production and support of pharmaceutical active ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. ...

Agriculture Industry Today: Biotechno...

Impact of Lactic Acid Bacteria on Dendritic Cells from Allergic ...
Lactic acid bacteria (LAB) are Gram positive nonpathogenic commensal organisms present in human gastrointestinal tract. In vivo, LAB are separated from antigen-presenting cells such as dendritic cells (DC) by the intestinal epithelial ...

Journal of Biomedicine and Biotechnol...

Biotechnology News

Biotechnology News

Open Biotechnology Journal
By BiotechBlog
I’ve been invited to join the editorial board of the nascent Open Biotechnology Journal. The Open Biotechnology Journal is a peer-reviewed open access journal and aims to publish original research papers in all core areas of ...

Biotech Blog

Which Biotech Ben?
By Keith Robison(Keith Robison)
If the biotech industry has lost a lot of money, who was making out on the deal? Employee compensation tends to be a big ticket item, so a lot went to the biotechies (especially the executives). Scientific supply houses obviously took a ...

Biotech Industry Leaders and Exciting Start-ups to Forge ...
By admin
Next Generation Companies: With increasing competition for late-stage assets, pharmaceutical companies are taking a greater interest in earlier stage biotech companies. In keeping with this trend, some of the most exciting early-stage ...

Biotech Acquisitions Up, IPO's Down
By Donald Zuhn
By Donald ZuhnA recent article at attributes the drop in initial public offerings (IPO's) for small biotech companies to the reluctance of investors to forgo big paydays as small biotechs use much of the cash raised ...

Florida: the Next Biotech Hub?
By 24/7 Wall St.
California and Boston, where biotech giants such as Genentech (DNA), Amgen (AMGN), and Biogen Idec (BIIB) were born, continue to be the leaders in biotechnology. But more and more states are initiating plans for large biotech research ...

Biotech News

Biotech News

Biotech IPO Filing: Endoceutics of Canada
24/7 Wall St. - New York,NY,USA
A Canadian biotech company named Endoceutics, Inc. has filed with the SEC to raise up to $75 million via an IPO. The underwriting group is listed as First ...

Biotech lab visits school - Salem,MA,USA
By Matthew J. Webster , Staff writer. MANCHESTER - Boston University's Citylab, a mobile biotechnology class, returned to Manchester Essex Regional High ...

Biotech Day in Review: Biotech Takes a 3% Hit Seeking Alpha - New York,NY,USA Centient Biotech Investor submits: Biotech followed the broad market lower on Tuesday, after the Shanghai stock exchange fell 9%. ...

MarketWatch - USA
By Val Brickates Kennedy, MarketWatch. BOSTON (MarketWatch) -- Investors on Wednesday appeared to take a defensive posture, pushing most pharmaceutical ...

Biotech News

Washington biotech industry ranks high
Seattle Post Intelligencer - Seattle,WA,USA Fierce Biotech names Washington state as one of the top five regions embracing the biotechnology industry, joining Florida, Singapore, California and ...

Biotech: `duty sops unaddressed'
Hindu - Chennai,India
The recommendation of the biotech industry to exempt from excise and customs duties components and raw materials remained unaddressed. ...

Nautilus Biotech announces IND filing for Belerofon, its oral ... (press release) - Barcelona,Spain PARIS, France | Feb 27, 2007 | Nautilus Biotech has announced that it has submitted an Investigational New Drug (IND) filing to the US Food and Drug ...